The following eleven diagnostic evaluations are specifically to address the multifaceted health needs of senior citizens, ensuring early detection, effective management, and enhanced quality of life, advises Dr Sujay Prasad
As we navigate the complexities of ageing, the adoption of the most comprehensive and proactive approach with respect to the management of individual’s health is required. The following eleven diagnostic evaluations are specifically to address the multifaceted health needs of senior citizens, ensuring early detection, effective management, and enhanced quality of life. These assessments incorporate insights from international standards, such as the U.S. Preventive Services Task Force (USPSTF), the World Health Organization’s Integrated Care for Older People (ICOPE) framework (updated in its second edition in January 2025), and comprehensive geriatric assessment (CGA) models emphasized in global reviews. While lab-based tests are valuable for targeted risks, international guidelines prioritise functional screenings (e.g., mobility, cognition) and evidence-based frequencies to avoid over testing, focusing on person-centred care.
- Comprehensive Blood Profile (CBC & ESR) Rationale: The Complete Blood Count (CBC) and Erythrocyte Sedimentation Rate (ESR) are key tests to evaluate overall health, detecting anaemia, infections, or inflammation. International standards, including USPSTF and WHO ICOPE, do not endorse routine annual screening for all seniors but support diagnostic use for symptoms; CGA models integrate this as part of multidimensional assessments for deficits in vitality or immunity. Recommended for:
- Seniors experiencing fatigue, unexplained weight loss, or frequent infections.
- ESR is essential for detecting inflammation, often in cases of autoimmune conditions or chronic diseases such as arthritis or vasculitis. When to do it:
- As needed for symptoms or as part of targeted health check-ups, rather than annually for all, the WHO ICOPE suggests monitoring intrinsic capacity (e.g., vitality) every 6 months if declines are noted.
2. Kidney Function Assessment (KFT & Microalbuminuria) Rationale: Kidney function deteriorates with age, and chronic kidney disease (CKD) can go unnoticed until it’s advanced. This aligns with USPSTF recommendations for screening in at-risk groups (e.g., via diabetes management) and WHO ICOPE’s focus on functional impacts like mobility affected by renal issues, though not as routine lab screening. CGA emphasizes integration with overall biopsychosocial evaluation. Recommended for:
- Individuals with high blood pressure, diabetes, or a family history of kidney disease.
- Those who have risk factors for renal complications or experience swelling in the legs or feet. When to do it:
- Annually or more frequently for those with existing diabetes, hypertension, or a family history of kidney disease, consistent with USPSTF B-grade evidence for related metabolic screenings.
3. Thyroid Function Evaluation (T3, T4, TSH) Rationale: Thyroid disorders, such as hypothyroidism and hyperthyroidism, are common among seniors and can impact overall health. However, USPSTF does not recommend routine screening due to insufficient evidence; it’s best used diagnostically. WHO ICOPE prioritizes functional assessments over labs unless symptoms link to vitality or mood declines. Recommended for:
- Seniors who are experiencing fatigue, unexplained weight changes, mood swings, or constipation.
- Particularly important for women, who are at higher risk for thyroid problems. When to do it:
- As symptoms arise or every 5 years for at-risk groups (e.g., women over 50), rather than annually, to align with evidence-based guidelines.
4. Diabetes Monitoring (Fasting Blood Glucose & HbA1c) Rationale: Diabetes is prevalent in older adults and can cause complications such as nerve damage, vision loss, and heart disease. This strongly aligns with USPSTF B-grade recommendations for screening in adults 35-70 with overweight or risks, and WHO ICOPE’s emphasis on preventing declines in intrinsic capacity. Recommended for:
- Individuals over 45 years old, especially those who are overweight, sedentary, or have a family history of diabetes. When to do it:
- Annually or as recommended by a healthcare provider, particularly if the senior has risk factors for diabetes, matching international standards.
5. Lipid Profile Analysis Rationale: High cholesterol and triglyceride levels are major contributors to heart disease, stroke, and arterial blockages. Supported by USPSTF through statin recommendations for ages 40-75 with risks, and integrated in CGA for cardiovascular health in seniors. WHO ICOPE links this to mobility and vitality. Recommended for:
- Seniors with a history of cardiovascular disease or those with hypertension, diabetes, or obesity. When to do it:
- Every 5 years routinely or more frequently if the individual has a history of heart disease or is on cholesterol-lowering medication, per evidence-based guidelines.
6. Bone Health Evaluation (Calcium & Vitamin D Levels) Rationale: Osteoporosis is a significant concern for seniors, leading to fragile bones and an increased risk of fractures. USPSTF B-grade recommends DEXA scans for women 65+, with blood tests as adjuncts for deficiencies. WHO ICOPE and CGA focus on falls prevention (e.g., exercise interventions) over routine labs. Recommended for:
- Seniors, especially women over 60, those who have a history of fractures, or who experience joint pain or stiffness.
- Those with limited sun exposure or dietary intake of calcium and vitamin D. When to do it:
- As risks or symptoms indicate, or in conjunction with functional mobility assessments every 6 months if needed, per WHO ICOPE.
7. Liver Function Assessment (LFT) Rationale: Liver function tests are essential for detecting liver conditions such as fatty liver disease, hepatitis, and cirrhosis. USPSTF recommends hepatitis C screening (B-grade) for ages 18-79 but not routine LFTs; use diagnostically. Aligns with CGA for medication impacts. Recommended for:
- Seniors who consume alcohol regularly or take medications that could impact liver health.
- Those with unexplained weight loss, jaundice, or a history of liver disease. When to do it:
- As risks warrant, not routinely annually, to match evidence from international standards.
8. Arthritis and Inflammatory Marker Testing (Rheumatoid Factor & ESR) Rationale: Arthritis, particularly rheumatoid arthritis, affects many seniors and can lead to severe joint damage. No routine screening in USPSTF or WHO ICOPE; diagnostic for symptoms, integrated with mobility assessments in CGA. Recommended for:
- Seniors with joint pain, stiffness, or swelling.
- Those who have a family history of arthritis or autoimmune diseases. When to do it:
- If joint issues are persistent, or if there is suspicion of autoimmune disorders, as part of a targeted health check-up.
9. Nutritional Status Evaluation (Iron Studies & Vitamin Levels) Rationale: Seniors are more prone to nutrient deficiencies, which can contribute to fatigue, weakened immunity, and cognitive decline. WHO ICOPE includes malnutrition screening via clinical tools (e.g., Mini Nutritional Assessment), with labs as adjuncts; USPSTF lacks routine endorsement. Recommended for:
- Seniors who experience fatigue, unexplained weight loss, or difficulty concentrating.
- Those with dietary restrictions or poor appetite, or who have chronic conditions affecting nutrient absorption. When to do it:
- As signs indicate or every 6 months if vitality declines, per ICOPE.
10. Urinary Health Screening (Urine R/M & Microalbuminuria) Rationale: Urinary health can decline with age, leading to conditions like incontinence, UTIs, or kidney damage. WHO ICOPE includes incontinence assessment in functional screenings; USPSTF uses for diabetes follow-up, not routine.
- Recommended for:
- Seniors with frequent urinary tract infections, diabetes, or kidney-related issues.
- Those who have symptoms like frequent urination, burning, or cloudy urine. When to do it:
- As risks or changes occur, integrated with person-centred care.
11. Prostate Cancer Genetic Risk Assessment (Inherited Cancer Genetic Testing) Rationale: Prostate cancer is one of the most common cancers among senior men, and certain genetic mutations can significantly increase the risk. Inherited cancer genetic testing helps to identify those at higher genetic risk, enabling early detection and personalized care. USPSTF D-grade against routine PSA; genetic testing limited to high-risk (e.g., family history), per ASCO and CGA cancer guidelines. Recommended for: · Men aged 50 and above with a family history of prostate cancer or other cancers. · Men diagnosed with prostate cancer at an early age (under 65). · Men of Ashkenazi Jewish descent, who are at higher risk for genetic mutations like BRCA1 and BRCA2. · Individuals with a known hereditary cancer syndrome in their family, including a history of breast cancer, ovarian cancer, or other cancers related to BRCA mutations. When to do it: · If diagnosed with prostate cancer, to understand the hereditary risk and influence treatment plans. · For those with a family history of prostate or other cancers, as part of a comprehensive cancer risk assessment. · Before preventive measures or considering genetic counselling for family members, particularly if there’s a history of hereditary cancer.
Dr Sujay Prasad, Chief Medical Director,
Neuberg Diagnostics
